On the other hand, it is worth mentioning that the IL-33/ST2 signaling has been reported to contribute to CML progenitor growth [30] and the pathogenesis of myeloproliferative neoplasms [31], but lacked assessment of host immune responses. Here, IL33 is linked to chronic myelogenous leukemia, BCR-ABL1 positive.